Next Article in Journal
Trauma Functioning and Well-Being in Children Who Receive Mental Health Aid after Natural Disaster or War
Previous Article in Journal
Diagnosis and Treatment of Children with a Radiological Fat Pad Sign without Visible Elbow Fracture Vary Widely: An International Online Survey and Development of an Objective Definition
 
 
Case Report
Peer-Review Record

Pediatric Lichen Myxedematosus: A Diagnostic and Management Challenge

Children 2022, 9(7), 949; https://doi.org/10.3390/children9070949
by Kelly K. Barry 1,2, Diana B. Reusch 2, Birgitta A. R. Schmidt 3 and Elena B. Hawryluk 2,4,*
Reviewer 1:
Reviewer 2: Anonymous
Children 2022, 9(7), 949; https://doi.org/10.3390/children9070949
Submission received: 27 May 2022 / Revised: 23 June 2022 / Accepted: 23 June 2022 / Published: 25 June 2022
(This article belongs to the Section Pediatric Dermatology)

Round 1

Reviewer 1 Report

An interesting case report about a very rare dermatological condition. I think the paper is eligible to be published in its current form.

Author Response

Please see attachment.

Author Response File: Author Response.docx

Reviewer 2 Report

The case report presented by authors is very informative. Considering the paucity of available case reports, authors raised a valid concern about the diagnostic criteria of NLM and SHJCM and it is arguable in adult and pediatric populations. Following comments are suggested for the manuscript.

1)      Line no. 61: There is irregularity in the text. Text mentioning “increased number of fibroblasts as well as histiocytes highlighted by CD163 immunohistochemistry staining (Figure 1b).” but figure 1b is H & E stain. No data for CD163 staining, please incorporate same or rephrase the sentence. Have authors performed Alcian blue staining in any of the cases, particularly in case 2?

2)      Abbreviation should be used cautiously in the manuscript, should be expanded wherever first used e.g. SHJCM (self-healing juvenile cutaneous mucinosis). Diagnostic (differential) criteria of SHJCM should also be mentioned in the Table 1 (if possible).

 

3)      Line number 67 “Lesions persist five years later.” Have authors followed up patient for 5 years. If so, Photograph of same to be incorporated for better interpretation.

 

4)      Line no. 88 and 89, No data to support CD34 and CD117, should be given as supplementary information if permissible by journal. 

 

Author Response

Please see the attachment.

Author Response File: Author Response.docx

Back to TopTop